Docs connections below.... Paragon Bioservices,
Post# of 83881
Paragon Bioservices, Inc., the University of Maryland BioPark’s largest tenant and one of its fastest-growing biotechnology companies, is celebrating another success with the announcement that it has entered into a definitive agreement under which Catalent, Inc., a New Jersey-based contract drug manufacturer, will acquire Paragon for $1.2 billion.
https://www.umaryland.edu/news/archived-news/...ired-f.php
CATALENT AND JOHNSON AND JOHNSON WORKING ON NEW VACCINE TOGETHER....
DOC WITH PREISDENT OF umb biopark....
![1937006150_IMG_0522.jpg](https://investorshangout.com/images/MYImages/1937006150_IMG_0522.jpg)
![366355474_IMG_0523.jpg](https://investorshangout.com/images/MYImages/366355474_IMG_0523.jpg)
![1425174988_IMG_0857.jpg](https://investorshangout.com/images/MYImages/1425174988_IMG_0857.jpg)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)